TSC2 and epilepsy: Various pre-clinical and clinical studies demonstrated that loss of function mutations of the genes encoding for the natural mTOR inhibitors TSC1 and TSC2 lead to aberrant mTOR signaling with consecutive development of cortical malformations and epilepsy [19].